𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized controlled study of a cosmetic treatment for mild acne

✍ Scribed by B. Capitanio; J. L. Sinagra; R. B. Weller; C. Brown; E. Berardesca


Book ID
108697164
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
135 KB
Volume
37
Category
Article
ISSN
0307-6938

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

Cosmetic products are not tested with the same rigour as medical treatments, but recent high-quality studies have shown significant reductions in changes of skin ageing with use of cosmetic antiageing products.

Aim:

To test whether a cosmetic 'anti-spot' two-step treatment containing a complex of seaweed-derived oligosaccharide and zinc would produce a significant improvement in mild acne.

Methods:

A double-blind, vehicle-controlled trial of this treatment was performed for 8 weeks on 60 age-matched participants with mild acne. they were divided into two groups: 30 participants were treated with vehicle control and 30 with the active treatment containing a seaweed-derived oligosaccharide complexed with 0.1% zinc pyrrolidone.

Results:

After 8 weeks, both groups had a reduction in comedones, papules and pustules, and this was significantly greater in the active than control group at 2, 4 and 8 weeks.

Conclusions:

Cosmetic products may offer some benefit for mild acne and still meet the requirements of the european cosmetic directive. in particular, the seaweed-derived oligosaccharide complexed with 0.1% zinc pyrrolidone used in this study produced a significant reduction in acne vs. a control treatment. cosmetic companies should conduct blinded controlled trials of their product's efficacy and publish the results.


📜 SIMILAR VOLUMES


Hypericum treatment of mild–moderate dep
✍ E. Schrader; B. Meier; A. Brattström 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode